Solving the crisis of asthma/COPD medication nonadherence with new “smart inhalers”.
Faculty Advisor Name
Kristy Liskey
Department
Department of Health Professions
Description
Asthma and COPD are two common chronic respiratory diseases that have the potential to result in acute life-threatening exacerbations. These episodes cost America’s healthcare system several billions of dollars annually and can be largely prevented through proper medication adherence. Objective: Assess the effectiveness of smart inhaler usage and biofeedback interpretation with medication adherence and quality of Asthma and/or COPD control. Design: Systematic literature review. Methods: Searches were done in PubMed, Wiley Online Library, ScienceDirect Database, and DynaMed utilizing the terms smart inhaler, asthma/COPD management, biofeedback, inhalation technique, SABA, LABA, and LAMA. In PubMed, the following limits and terms were used: published within 10 years, randomized control trials (RCTs), adult population, US or similar geographical location, and English. Results: Three studies met inclusion/exclusion criteria: Sulaiman et al., Moore et al., and O’Dwyer et al. Conclusion: The use of smart inhalers and biofeedback is a safe and efficient way to improve medication adherence among patients with asthma and/or COPD. Factors necessary for proper management such as frequency of use and technique can be evaluated and utilized with smart inhalers. Implementation of these devices in clinical practice as well as research on cost-effectiveness should be discussed in future studies.
Solving the crisis of asthma/COPD medication nonadherence with new “smart inhalers”.
Asthma and COPD are two common chronic respiratory diseases that have the potential to result in acute life-threatening exacerbations. These episodes cost America’s healthcare system several billions of dollars annually and can be largely prevented through proper medication adherence. Objective: Assess the effectiveness of smart inhaler usage and biofeedback interpretation with medication adherence and quality of Asthma and/or COPD control. Design: Systematic literature review. Methods: Searches were done in PubMed, Wiley Online Library, ScienceDirect Database, and DynaMed utilizing the terms smart inhaler, asthma/COPD management, biofeedback, inhalation technique, SABA, LABA, and LAMA. In PubMed, the following limits and terms were used: published within 10 years, randomized control trials (RCTs), adult population, US or similar geographical location, and English. Results: Three studies met inclusion/exclusion criteria: Sulaiman et al., Moore et al., and O’Dwyer et al. Conclusion: The use of smart inhalers and biofeedback is a safe and efficient way to improve medication adherence among patients with asthma and/or COPD. Factors necessary for proper management such as frequency of use and technique can be evaluated and utilized with smart inhalers. Implementation of these devices in clinical practice as well as research on cost-effectiveness should be discussed in future studies.
